The Impact of SARS-CoV-2 Infection in Unvaccinated Multiple Sclerosis Patients on Disease-Modifying Therapies

OBJECTIVE: Disease-modifying therapies (DMTs) in multiple sclerosis (MS) may affect the course and outcome of COVID-19, but withholding them could permit disease activity. This study aimed to understand the course of COVID-19 in unvaccinated patients with MS on disease-modifying therapies. SUBJECTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Shammri, Suhail, Chadha, Geeti, Chattopadhyay, Arpita, Doi, Suhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319087/
https://www.ncbi.nlm.nih.gov/pubmed/37231972
http://dx.doi.org/10.1159/000530764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319087/
https://www.ncbi.nlm.nih.gov/pubmed/37231972
http://dx.doi.org/10.1159/000530764

Ejemplares similares